Haemoglobin (g/dL) · people with non‐transfusion‐dependent β‐thalassaemia
1 finding from 1 review
Measures of HbF · people with non‐transfusion‐dependent β‐thalassaemia
1 finding from 1 review
QoL · people with non‐transfusion‐dependent β‐thalassaemia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events · people with non‐transfusion‐dependent β‐thalassaemia
It is very uncertain whether single foetal haemoglobin inducer at any dose or duration changes adverse events compared with usual care or placebo (very low certainty).
1 finding from 1 review
Time to next pulmonary exacerbation · adolescents and adults with cystic fibrosis
Digital technology probably leads to higher time to next pulmonary exacerbation compared with usual care (moderate certainty).
1 finding from 1 review
Exacerbations (number of people experiencing ≥ 1 exacerbations) · adolescents and adults with cystic fibrosis
Digital technology showed no clear difference in number of pulmonary exacerbations: number of participants… compared with usual care (moderate certainty).
1 finding from 1 review
Quality of life: change from baseline in CFQ‐R · adolescents and adults with cystic fibrosis
Digital technology showed no clear difference in qoL: change from baseline in CFQ‐R score compared with usual care (moderate certainty).
1 finding from 1 review
FEV1 (% predicted): mean change from baseline · adolescents and adults with cystic fibrosis
1 finding from 1 review
IV antibiotics: number of days on IV antibiotics · adolescents and adults with cystic fibrosis
Digital technology showed no clear difference in IV antibiotics: number of days on IV antibiotics compared with usual care (low certainty).
1 finding from 1 review
New micro‐organisms: number of participants in whom new organisms are detected · adolescents and adults with cystic fibrosis
Digital technology probably leads to lower new micro‐organisms: number of participants in whom new organisms… compared with usual care (moderate certainty).
1 finding from 1 review
Adverse events: number of treatment related adverse events · adolescents and adults with cystic fibrosis
1 finding from 1 review
Change in quality of life · postural abnormalities in people with cystic fibrosis
1 finding from 1 review
Change in pain (mm) · postural abnormalities in people with cystic fibrosis
1 finding from 1 review
Change in trunk deformity (cm) · postural abnormalities in people with cystic fibrosis
1 finding from 1 review
Lung function: FEV1 mL (change from baseline) · postural abnormalities in people with cystic fibrosis
1 finding from 1 review
Change in FVC · postural abnormalities in people with cystic fibrosis
1 finding from 1 review
Change in ERV (L) · postural abnormalities in people with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Change in TLC (L) · postural abnormalities in people with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of minor postoperative bleeding episodes · People with haemophilia (A or B) undergoing minor oral surgery or dental extractions
The review found no eligible studies for this question.
1 finding from 1 review
Antifibrinolytic therapy (tranexamic acid or epsilon aminocaproic acid) vs Placebo, no intervention or usual care (with or without placebo)
Outcome not reported · People with Von Willebrand disease undergoing minor oral surgery or dental extractions
The review found no eligible studies for this question.
1 finding from 1 review